The growth hormone receptor interacts with its sheddase, the tumour necrosis factor-alpha-converting enzyme (TACE)
- PMID: 14519102
- PMCID: PMC1223864
- DOI: 10.1042/BJ20031321
The growth hormone receptor interacts with its sheddase, the tumour necrosis factor-alpha-converting enzyme (TACE)
Abstract
Proteolysis of the GHR (growth hormone receptor) occurs at the cell surface and results in the release of its extracellular domain, the GHBP (growth hormone-binding protein). TACE (tumour necrosis factor-alpha-converting enzyme) has been identified as a putative protease responsible for GHR cleavage. However, GHR-TACE interaction has not been observed until now. Here, we identified TACE in Chinese hamster cells and confirmed processing and cell-surface expression. Interaction between GHR and TACE was only observed after growth hormone binding. As the growth hormone-GHR(2) complex is a poor substrate for TACE, we conclude that the GHR-TACE interaction precedes proteolysis, and is transient. Furthermore, we demonstrate that TACE is present in endosomes, where it partly co-localizes with endocytosed growth hormone ligand.
Similar articles
-
Tumor necrosis factor-alpha converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: the metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation.Endocrinology. 2000 Dec;141(12):4342-8. doi: 10.1210/endo.141.12.7858. Endocrinology. 2000. PMID: 11108241
-
Metalloprotease-mediated GH receptor proteolysis and GHBP shedding. Determination of extracellular domain stem region cleavage site.J Biol Chem. 2002 Dec 27;277(52):50510-9. doi: 10.1074/jbc.M208738200. Epub 2002 Oct 25. J Biol Chem. 2002. PMID: 12403792
-
Janus kinase 2 influences growth hormone receptor metalloproteolysis.Endocrinology. 2006 Jun;147(6):2839-49. doi: 10.1210/en.2005-1484. Epub 2006 Feb 23. Endocrinology. 2006. PMID: 16497804
-
Growth hormone binding protein. The soluble growth hormone receptor.Minerva Endocrinol. 2002 Dec;27(4):265-76. Minerva Endocrinol. 2002. PMID: 12511849 Review.
-
Metalloproteinases and the modulation of GH signaling.J Endocrinol. 2002 Sep;174(3):361-8. doi: 10.1677/joe.0.1740361. J Endocrinol. 2002. PMID: 12208655 Review.
Cited by
-
Growth hormone proteoformics atlas created to promote predictive, preventive, and personalized approach in overall management of pituitary neuroendocrine tumors.EPMA J. 2023 Jun 27;14(3):443-456. doi: 10.1007/s13167-023-00329-1. eCollection 2023 Sep. EPMA J. 2023. PMID: 37605654 Free PMC article. Review.
-
Contribution of ADAM17 and related ADAMs in cardiovascular diseases.Cell Mol Life Sci. 2021 May;78(9):4161-4187. doi: 10.1007/s00018-021-03779-w. Epub 2021 Feb 11. Cell Mol Life Sci. 2021. PMID: 33575814 Free PMC article. Review.
-
The ADAM metalloproteinases.Mol Aspects Med. 2008 Oct;29(5):258-89. doi: 10.1016/j.mam.2008.08.001. Epub 2008 Aug 15. Mol Aspects Med. 2008. PMID: 18762209 Free PMC article. Review.
-
Immunomodulatory role of metalloproteinase ADAM17 in tumor development.Front Immunol. 2022 Nov 17;13:1059376. doi: 10.3389/fimmu.2022.1059376. eCollection 2022. Front Immunol. 2022. PMID: 36466812 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous